MatchaDB

2022学術論文無料で読める

Matcha green tea targets the gut-liver axis to alleviate obesity and metabolic disorders induced by a high-fat diet.

Wang Y, Yu Y, Ding L, Xu P, Zhou J

Frontiers in nutrition

出版社で読む→無料の全文→PubMedPubMed Central

要旨

Obesity induced by a high-fat diet (HFD) is an increasing global health problem, leading to many metabolic syndromes. As the emerging food additive rich in tea polyphenols, theanine, caffeine, and so on, matcha green tea has gained more and more popularity for its outstanding potential in ameliorating metabolic disorders. This study investigated the composition and antioxidant activity of matcha green tea and further explored its effects on gut-liver axis homeostasis in an HFD-induced obese mouse model. Male (7-8 weeks old) C57BL/6J mice were divided into four groups with the following dietary supplementation for 8 weeks: a normal chow diet (NCD), a normal chow diet+1.0% matcha (NCM), a high-fat diet (HFD), and a high-fat diet+1.0% matcha (HFM). The results demonstrated that matcha green tea ameliorated the development of obesity, lipid accumulation, and hepatic steatosis induced by HFD. Subsequently, dietary matcha supplementation restored the alterations in fecal bile acid profile and gut microbial composition. Meanwhile, the levels of mRNA expression in hepatocytes demonstrated that matcha intervention made significant regulatory on the multiple metabolic pathways of hosts involved in glucose, lipid, and bile acid metabolism. These findings present new evidence for matcha green tea as an effective nutritional strategy to mitigate obesity and relevant metabolic disorders through the gut-liver axis.

要旨の文章はPubMed、OpenAlex、Europe PMCから取得したもので、著者と出版社に帰属します。

研究の種類

動物研究

マウス、ラット、魚などの動物での実験。

タイトル、要旨、件名から自動的に割り当てています。

トピック

ここでは抹茶が主題のひとつです(タイトルに記載)。

キーワードと件名

あなたのリサーチフォルダー

この研究を引用する

Wang Y, Yu Y, Ding L, Xu P, Zhou J. (2022). Matcha green tea targets the gut-liver axis to alleviate obesity and metabolic disorders induced by a high-fat diet. Frontiers in nutrition. https://doi.org/10.3389/fnut.2022.931060

DOI: 10.3389/fnut.2022.931060 · PubMed ID: 35978960 · 被引用30件(OpenAlex)

代謝と体重についてさらに

2018学術論文

Effect of tea products on the in vitro enzymatic digestibility of starch.

Zhang H, Jiang Y, Pan Jほか — Food chemistry

The importance of postprandial hyperglycemia in the treatment of diabetes has been recognized recently. Tea products, such as tea polyphenols (TP), epigallocatechin gallate (EGCG), matcha, and instant tea, were chosen as constituents of…

試験管内・細胞研究代謝と体重抗酸化物質とポリフェノール腸とマイクロバイオーム被引用76回
2018学術論文無料で読める

Matcha green tea (MGT) inhibits the propagation of cancer stem cells (CSCs), by targeting mitochondrial metabolism, glycolysis and multiple cell signalling pathways.

Bonuccelli G, Sotgia F, Lisanti MP — Aging

Matcha green tea (MGT) is a natural product that is currently used as a dietary supplement and may have significant anti-cancer properties. However, the molecular mechanism(s) underpinning its potential health benefits remain largely…

試験管内・細胞研究代謝と体重抗酸化物質とポリフェノールがん被引用75回
2020学術論文

Changes in Intestinal Microbiota of Type 2 Diabetes in Mice in Response to Dietary Supplementation With Instant Tea or Matcha.

Zhang HH, Liu J, Lv YJほか — Canadian journal of diabetes

Objective: Gut microbiota plays a key role in metabolism and health in diabetes patients with gastrointestinal microbiota dysbiosis. Thus, regulating the ecological balance of gut microbiota may provide a pathway toward improvement for…

動物研究代謝と体重腸とマイクロバイオーム市場・文化・持続可能性被引用74回

ライブラリ全体を見る→